Two-year randomized clinical evaluation of catechin doped in a universal adhesive on non-carious cervical lesions restorations

Abstract Objectives This randomized, blinded clinical trial evaluated the 24-month clinical performance of a universal adhesive (Single Bond Universal) containing 0.1 wt% epigallocatechin-3-gallate (EGCG) for the restoration of non-carious cervical lesions (NCCLs using self-etch and etch-and-rinse strategies. Materials and methods A total of 160 restorations were placed in 29 patients and randomly allocated to four groups: etch-and-rinse (ER), etch-and-rinse with EGCG (ER-EGCG), self-etch (SE), and self-etch with EGCG (SE-EGCG). EGCG was directly incorporated into the adhesive, which was applied according to the manufacturer’s instructions. All lesions were restored with a nanofilled composite resin (Filtek Z350XT) and evaluated at baseline and after 6, 12, 18, and 24 months according to the World Dental Federation criteria. Data were analyzed using the Kruskal–Wallis and McNemar tests (α = 0.05). Results Participant recall rates were 100% at baseline and 6 months, and 93.1%, 89.7%, and 72.4% at 12, 18, and 24 months, respectively. No significant differences were observed among groups for any evaluated clinical criterion throughout the 24-month follow-up ( p > 0.05). At 24 months, retention rates were 90% for SE and SE-EGCG and 100% for ER and ER-EGCG. No significant differences were observed between baseline and 24-month evaluations within any group ( p > 0.05). Incorporation of 0.1 wt% EGCG into the universal adhesive did not compromise the clinical performance of NCCL restorations over 24 months, regardless of the bonding strategy. Conclusions Incorporation of 0.1 wt% EGCG into a universal adhesive did not affect the clinical performance of NCCL restorations over 24 months. Clinical Relevance: Incorporation of 0.1 wt% EGCG into a universal adhesive did not improve the clinical performance of NCCL restorations over 24 months compared with the unmodified adhesive. However, EGCG incorporation did not adversely affect restoration performance when the adhesive was used with either etch-and-rinse or self-etch strategies.

Authors

Institutions

Publication Details

Journal
Clinical Oral Investigations
Published
2026-11-14
DOI
https://doi.org/10.1007/s00784-026-07282-z
Primary Topic
Dental materials and restorations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Two-year randomized clinical evaluation of catechin doped in a universal adhesive on non-carious cervical lesions restorations

Cecília Atem Gonçalves de Araújo Costa, Sérgio Lima Santiago, Ana Laura Mendes Mota, Juliano Sartori Mendonça et al.
Clinical Oral Investigations
Dental materials and restorations
article

Two-year randomized clinical evaluation of catechin doped in a universal adhesive on non-carious cervical lesions restorations

Cecília Atem Gonçalves de Araújo Costa, Sérgio Lima Santiago, Ana Laura Mendes Mota, Juliano Sartori Mendonça, Nadine Luísa Guimarães Albuquerque, Vicente de Paulo Aragão Sabóia
article en

Abstract

Abstract Objectives This randomized, blinded clinical trial evaluated the 24-month clinical performance of a universal adhesive (Single Bond Universal) containing 0.1 wt% epigallocatechin-3-gallate (EGCG) for the restoration of non-carious cervical lesions (NCCLs using self-etch and etch-and-rinse strategies. Materials and methods A total of 160 restorations were placed in 29 patients and randomly allocated to four groups: etch-and-rinse (ER), etch-and-rinse with EGCG (ER-EGCG), self-etch (SE), and self-etch with EGCG (SE-EGCG). EGCG was directly incorporated into the adhesive, which was applied according to the manufacturer’s instructions. All lesions were restored with a nanofilled composite resin (Filtek Z350XT) and evaluated at baseline and after 6, 12, 18, and 24 months according to the World Dental Federation criteria. Data were analyzed using the Kruskal–Wallis and McNemar tests (α = 0.05). Results Participant recall rates were 100% at baseline and 6 months, and 93.1%, 89.7%, and 72.4% at 12, 18, and 24 months, respectively. No significant differences were observed among groups for any evaluated clinical criterion throughout the 24-month follow-up ( p > 0.05). At 24 months, retention rates were 90% for SE and SE-EGCG and 100% for ER and ER-EGCG. No significant differences were observed between baseline and 24-month evaluations within any group ( p > 0.05). Incorporation of 0.1 wt% EGCG into the universal adhesive did not compromise the clinical performance of NCCL restorations over 24 months, regardless of the bonding strategy. Conclusions Incorporation of 0.1 wt% EGCG into a universal adhesive did not affect the clinical performance of NCCL restorations over 24 months. Clinical Relevance: Incorporation of 0.1 wt% EGCG into a universal adhesive did not improve the clinical performance of NCCL restorations over 24 months compared with the unmodified adhesive. However, EGCG incorporation did not adversely affect restoration performance when the adhesive was used with either etch-and-rinse or self-etch strategies.

Clinical Oral InvestigationsVol. 30(12)
Universidade Federal do Ceará (BR)
Dental materials and restorations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon